Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Korro Bio, Inc. (KRRO) had Days Sales in Receivables of 67.91 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$2.55M |
|
$-23.39M |
|
-- |
|
$2.55M |
|
$27.57M |
|
$-25.02M |
|
$1.63M |
|
$-23.39M |
|
$-23.39M |
|
$-23.39M |
|
$-23.39M |
|
$-23.39M |
|
$-23.39M |
|
$-25.02M |
|
$-24.14M |
|
9.38M |
|
9.38M |
|
$-2.49 |
|
$-2.49 |
|
| Balance Sheet Financials | |
$121.23M |
|
$26.68M |
|
$80.97M |
|
$202.21M |
|
$12.88M |
|
-- |
|
$50.37M |
|
$63.25M |
|
$138.96M |
|
$138.96M |
|
$138.96M |
|
9.39M |
|
| Cash Flow Statement Financials | |
$-24.45M |
|
$32.78M |
|
$0.17M |
|
$59.05M |
|
$67.55M |
|
$8.50M |
|
$1.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-981.18% |
|
-981.18% |
|
-- |
|
-917.14% |
|
-917.14% |
|
$-24.57M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
1.33 |
|
|
Days Sales in Receivables |
67.91 |
-16.83% |
|
-16.83% |
|
-11.57% |
|
-16.83% |
|
$14.80 |
|
$-2.62 |
|
$-2.61 |
|